drug protocol number

NCT0643080

drug sponsor

Merck sharp & Dohme

drug study

Tulisokibart

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital NG (Riyadh), King Saud University Medical City (Riyadh), King Abdullah Medical City Specialist Hospital (Makkah)

drug status

Ongoing

drug phase